P
COMPANY PROFILE
PolyTherics
Biopharmaceutical conjugation technology for therapeutic drug development
Valuation
$10–25M
Last recorded · 2011
Revenue
<$1M
Latest reported FY
Headcount
100–500
Current team size
Total funding
$10–50M
Disclosed equity funding
At a glance
- Founded
- 2001
- Headquarters
- Coventry, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Imperial Innovations
Longbow Capital
Series B and later1 investor entered at this stage
- TFThe Capital Fund
Team profiled
8
named & role-tagged
Founders
Hidden — book a demo/100
quality score
Key operators
3
quality Hidden — book a demo/100
Potential founders
Hidden — book a demo
likely future founders
Startup mafia
Hidden — book a demo
alumni-founded startups
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about PolyTherics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PolyTherics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.